目的:探讨生物学标记物对预测肝癌移植术后复发的价值。方法:回顾性分析2002年4月至2005年11月50例肝癌移植病例,存活者至少随访12月,石蜡切片做免疫组化检测E-cadherin、β-catenin、Ki-67的表达,分析其与复发、生存时间的相关性并与一些主要临床病理指标进行比较。结果:TNM分期、门静脉癌栓仅在单变量分析中对预测复发、生存时间有意义(P〈0.05),术前血清AFP仅在多变量分析中与复发有关(OR=2.552,P〈0.05);胞膜E-cadherin低表达、核β-catenin阳性、核Ki-67高增殖指数在单变量分析中对预测复发、生存时间的统计学意义均显著,而且在多变量分析中结果类似(均P〈0.01),但胞膜β-catenin表达和预后无关(P〉0.05)。结论:这3个生物学标记物有前景成为肝癌移植术后复发的预后因子,且价值可能优于临床病理指标。
AIM: To investigate the prognostic value of biomarkers on predicting recurrence of hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT). METHODS: Fifty patients with HCC who underwent OLT between April 2002 and November 2005 with a minimum clinical follow up of 12 months were included in this retrospective study. We examined immunohistochemical expression of E - cadherin with β - catenin, Ki - 67 proliferative index and analyzed the correlation between these biomarkers with recurrence and survival, along with the main clinical - pathological variables. RESULTS: Only at univariate analysis, TNM, portal vein tumor thrombi were valuable on predicting recurrence and survival time ( P 〈 0. 05 ), and preoperative serum AFP correlate to recurrence only at multivariate analysis ( OR = 2. 552, P 〈 0. 05). Lower membrane expression of E - cadherin, nuclear β - catenin localization and high Ki - 67 index showed notable significance on predicting recurrence and survival time at univariate analysis, as well at multivariate analysis, all P 〈 0. 01. The membrane expression of β- catenin did not correlate to the prognosis ( P 〉 0.05 ). CONCLUSION: These three biomarkers might have potential as a tumor prognostic marker for predicting recurrence of HCC after OLT and perhaps are better than the clinical - pathological variables.